William Doyle, president and CEO of Vystar Corporation, presented “The Non Enzymatic Deproteinization of Natural Rubber Latex (DPNRL) Enabling the Greater Versatility in End Product Applications,” detailing the benefits of Vytex NRL technology in end product applications at the prestigious India Rubber Expo & Tyre Show in Mumbai, India. Click here
to see the Vystar presentation and here
for the presentation's talking points.
William Doyle, president and CEO of Vystar Corporation, presented at Sidoti & Company’s sixth Semi-Annual Micro-Cap Conference on January 7, 2013 in New York City. An estimated 1,000 people attended to hear presentations from over 70 companies. Click here
to see the Vystar presentation.
William Doyle, president and CEO of Vystar Corporation, presented at this annual conference along with more than 100 other small and micro-cap companies from a broad range of industries. Click here
to see and hear the presentation. (Please note: You will need to register to see the presentation. Also, if you have difficulty, try using a different browser.)
Vytex natural rubber latex creator Vystar Corp. has acquired SleepHealth LLC to give the company another avenue for expansion. Vystar will help SleepHealth gives Vystar a strong growth opportunity.
Vystar's Vytex NRL is at the forefront of a "Fashion Hygiene" revolution. It's the key ingredient in new form-fitting protective undergarments, developed by Tamicare, a company based near Manchester, UK, that is currently building a proprietary commercial production line.
Cosyflex fabrics are made directly for cellulose fibers and Vytex NRL, a patented, all natural raw material that retains the positive properties of latex. The result is a material that is both breathable and leak resistant. The effort that went into the specific Vytex NRL compound used for Cosyflex is a good example of how Vystar's professional support program helps companies solve their latex product development challenges and launch their products.
Vystar Corp. has become a chameleon of sorts, adapting quickly in a constantly changing environment. It's a technology company that repeatedly has branched out while surviving its share of lows, as emerging as a stronger business.
"Despite global economic and political factors that might have predicted otherwise, MlT Sloan Management Review and The Boston Consulting Group 2011 global study , Sustainability : The "Embracers"Seize Advantage, reveals that corporate commitments to sustainability driven management are strengthening.
DULUTH, Ga.—Vystar Corp. is moving into the product manufacturing arena.
The creator and producer of Vytex natural rubber latex has agreed to merge with EcoGlove Asia Pacific Sdn. Bhd., an inventor and maker of sustainable, reusable examination gloves.
The proposal is nonbinding and subject to the completion of due diligence by both Vystar and EcoGlove. Terms of the merger have not been finalized, the firms said, but both companies are hoping to complete the deal by Sept. 30.
"Gloves are one of the most prolific supplies in the operating room, providing barrier protection to surgeons' and nurses' hands against contact with patients' blood and other body fluids, as well as microorganisms."
Diane Brandon's internet radio program "Naturally Vibrant Living" focuses on green living, health & wellness and the environment. She recently interviewed Bill Doyle about the Green chemistry Vystar uses to make Vytex NRL .
For decades, natural rubber latex has been an essential component in many of the items we use everyday, particularly when it comes to medical and health-related usage. But with increased usage of latex, particularly in the late 1980's, came the emergence of a sometimes-fatal side effect, latex allergies. Enter Duluth, GA-based Vystar, and its President, Bill Doyle.
Latex gloves, and latex in general, has had a huge role in preventing the spread of infectious diseases like HIV/AIDS. But 3% of medical workers are allergic to latex, and when professionals that develop an allergy over time are added to the equation, that rate can rise up to 17%. Accommodating that ratio of workers is a headache--tactics like denaturing latex materials with gloves and hot water use massive amounts of resources and time. With 75 gloves used per hospital bed, there is plenty of room for an alternative.
Latex is everywhere. It coats Mackintosh rain coats. It covers the hair of championship swimmers. It keeps pathogens away in the surgery room. It's Catwoman's signature look. And, of course, it's the foundation for the modern contraceptive industry.
Latex is everywhere. It coats Mackintosh rain coats. It covers the hair of championship swimmers. It keeps pathogens away in the surgery room. It's Catwoman's signature look. And, of course, it's the foundation for the modern contraceptive industry.
More than 40,000 types of commercial products are made from natural rubber latex (NRL), an extract of the Pará rubber tree. Valued for its desirable properties, NRL is used in numerous products in the medical industry and elsewhere, including latex gloves. However, out of more than 200 proteins contained within NRL, 13 are known to be allergens. The American Latex Allergy Association estimates that up to 1 percent of the general population and 17 percent of health care workers exhibit some form of latex allergy, thus hindering their use of gloves made from this material.
Bill is interviewed by Accelerator Avenue
Bill is interviewed by The Nurses Station
Customers of Duluth-based Vystar Corp. have found various uses for its Vytex brand natural rubber latex, using it in adhesives, exam gloves, pillows, surgical gloves and condoms.
Vytex NRL is featured in the magazines Upfront Innovations
on page 8
Vystar’s President Bill Doyle addresses the issue of latex allergies in the healthcare setting and the potential solution using modified latex to remove antigenic proteins,
Jack Callicutt, Vystar CFO is interviewed on the impact of the dollar on global business
To learn about currency, just plan a trip across the ocean. Convert your money to foreign funds, then book airline tickets, hotels and trains. Suddenly, you’ll find out how the dollar is doing in, say, Europe, and how much value is lost in translation. Vystar Corp., of Duluth, manufactures latex in Guatemala, Malaysia and Thailand. The company tries to minimize risk by using contracts written in dollars. That means the other party has to switch currencies when it is time to pay — at whatever the exchange rate is at the time.
William R. Doyle, Vystar President and CEO discusses the evolution and importance of green chemistry in manufacturing.
So-called green chemists use all the tools and training of traditional chemistry, but instead of ending up with toxins that must be treated after the fact, they aim to create industrial processes that avert hazard problems altogether. The result is new materials that are not only safer to use but less expensive to make. Yet a decade after the phrase “green chemistry” was coined, less than 1% of patents in chemical-heavy industries are green.
William R. Doyle, Vystar President and CEO is interviewed on the strengthening economic ties between Latin American and Asia.
For Vystar Corp., a US-based latex producer, logistics play an important role in Latin American–Asian trade. “When I think of the logistical challenges in the markets that Vystar serves—for example, medical gloves produced in Malaysia and exported to the US—I wonder if there is a more cost-effective and environmentally sound approach to this market, “says Bill Doyle, Vystar’s CEO and chairman.
William R. Doyle, president and ceo, Vystar Corporation, explains how removing antigenic proteins from latex enhances performance and reduces potential for allergic reactions.
More than 40,000 products are made from natural rubber latex, including gloves. However, out of more than 200 proteins within natural rubber latex, 13 are known to be allergens. It has been estimated that 3% of the general population, including 17% of healthcare workers, exhibit some form of latex allergy, hindering their use of such gloves.
Latex allergies can complicate the use of products such as gloves, bandages, catheters, and condoms. A multipatented modified latex production process offers a potentially safer alternative.
There are more than 40,000 types of commercial products that are made from natural rubber latex (NRL), an extract of the Pará rubber tree (Hevea brasiliensis). Valued for its desirable properties, NRL is used in numerous products in the medical industry, including latex gloves, adhesive bandages, catheters, breather bags, and condoms. However, out of more than 200 proteins contained within NRL, 13 are known to be allergens. Fortunately, a solution exists for removing the antigenic proteins that can cause such immune responses.
Vystar President and CEO William R. Doyle highlights the drivers behind the creation of Vytex Natural Rubber Latex, the many applications benefiting from Vytex’s unique characteristics and its green, environmentally friendly footprint in an interview with MO.com, a leading global entrepreneurial site.
Consumers with allergies to natural rubber latex, aka NRL, may get some relief from a new type of latex condom that retains all of the advantages of traditional latex and (almost) none of the allergens. Plus, an added bonus is that the new condom is claimed to be more environmental friendly. However, US biotech company Vystar Corporation announced in a news release on October 8 that it has developed a series of patents on a new type of low-protein variant of NRL with the brand name of Vytex. Its first commercial product, the Envy Ultra Thin Condom, has been approved by the US Food and Drug Administration.
The use of Vytex® Natural Rubber Latex is a logical move for manufacturers that use standard latex across a broad scope of industries, including medical manufacturing states Bill Doyle, Vystar’s President and CEO. He goes on to say the overall performance benefits and attributes of this aluminum hydroxide modified latex offer a unique value proposition to manufacturers, allowing them to capitalize on its green advantages while addressing health and safety concerns.
Vystar President and CEO Bill Doyle tells the story of the early days of Vystar and the challenges of scaling up production and operations to meet the demand for manufacturer evaluations and creating a marketing strategy on a shoe-string budget. Bill comments “we had almost no marketing or advertising budget. Buying one ad in a popular magazine would have wiped out our annual marketing budget, so instead we started writing technical papers and going to latex conferences to speak about our product. We also worked with PR firms to try to get some buzz going around our new green, reduced antigenic protein product.
When rubber investors flock to invest, the usual corporate bar¬ons, the CEO’s, the big boys of the medical industry, show up at the Board Room--American Bantex, Lumex and Duro-Med, all heavily dependent on the all-purpose rubber tree. That resource has been a God-send to the industry, providing the material for about 40,000 modern items, from sterilized gloves for doctors to everyday chewing gum. Natural latex has provided a green perspective in the business, promoting sustainable material that is also environmental-friendly. Using this as a foundation, Vystar® has created a better natural latex, one that actually reduces the common allergy-causing proteins normally found in natural rubber latex without reducing its quality and performance.
An aluminum hydroxide-modified latex production process offers a safer alternative to latex-based adhesives and sealant says William R. Doyle, President and CEO, Vystar, in an article published in the August edition of the magazine and online at www.adhesivesmag.com
Bill Doyle, President and CEO was featured in an interview on Canada's Business News Network (BNN) "SqueezePlay" program. Hosts
Andrea Mandel-Campbell and Rudyard Griffiths covered the history of Vystar, the benefits of Vytex NRL, and the market potential with the
seven different industries targeted for Vytex NRL. BNN is Canada’s all business specialty channel that provides comprehensive real time coverage
of global market activity from a Canadian perspective. To view the segment, click here
More than 40,000 types of commercial products are made from
natural rubber latex (NRL)—from gloves and condoms to
balloons, mattresses and pillows. It’s been estimated that 3
percent of the general population suffers from some form of
latex allergy, thus hindering their ability to use these and other
products. Yet a remarkable new technology is not only capable
of removing virtually all of the proteins in latex that cause
allergy symptoms, but also saving precious water and energy in
Spring brings longer, warmer days, along with a variety of flowers waking up from their winter slumber.
With these flowers come a wide range of allergies ranging from pollen of a ragweed to Bermuda grass,
from different flowers to a long list of trees. If you have these spring time allergies, you understand what
it is like to have a misguided reaction to what your immune system recognizes as a foreign substance.
One allergy that has grown in prevalence over the last couple of decades is the allergy to latex. Around
3 percent of the U.S. population is at risk of having an allergic reaction to natural rubber latex according to
The latex industry can continue to be profitable and competitive without wasting natural resources
thanks to green improvements, says a new technical paper. Co-author William R. Doyle, who is also
the president and CEO of Vystar Corporation, a leading latex manufacturer based out of Duluth,
Georgia, says that recognizing the need for and importance of natural products that minimize
environmental impact while maximizing economic, health and safety benefits is critical to the
sustainability of the latex industry.
A new multi-patented process produces a natural rubber latex material with virtually undetectable
levels of the antigenic proteins that can cause latex allergy, with the natural material also taking
aim at "synthetic" alternatives, including vinyl, styrene, nitrile, choloroprene, and polyurethane.
to listen to audio podcast aired during the week of March 21st by over 360 radio stations in 231 geographical markets
(88.3% of US population), including 9 of the top 10 radio markets: New York, Los Angeles, Chicago, San Francisco,
Houston, Atlanta, Boston, Washington DC and Philadelphia.
Newswise — The latex industry can continue to be profitable and competitive without wasting natural
resources thanks to green improvements, says a new technical paper. According to co-author, William
R. Doyle, President and CEO of Vystar Corporation, believes what is critical to the sustainability of the
latex industry is recognizing the need for and importance of natural products that minimize environmental
impact while maximizing economic, health and safety benefits.
People allergic to polyurethane could face problems if they shop at a big box store because
many of the products there contain that substance. Products that contain polyurethane include
memory foam mattresses and some pillows. Allergic reactions to polyurethane can include itching
eyes or skin, difficulty breathing, an irregular heartbeat and other symptoms. It isn't just touching
the product that causes problems because polyurethane exudes fumes into the air.
People who are allergic to polyurethane might have an unpleasant experience if they shop
at a big box store because many of the products there contain that substance. Products that
contain polyurethane include some things that consumers might not expect, such as memory
foam mattresses and some pillows.
Vystar President and CEO William Doyle in an in depth interview with a leading industry trade journal speaks on how Vytex NRL is opening the door for a new era of safer latex products.
Research has shown that allergy may play a role in the pathogenesis of autism. The authors explore the issue of proteins and how allergic immune responses may induce the production of brain auto-antibodies.
The Envy condom was included as part of the coverage surrounding the day of the Atlanta AIDS Walk.
Bill Doyle discussed the new Envy condom and the launch of the product at the Atlanta AIDS Walk.
AID Atlanta Executive Director mentioned the Envy condom product launch at the Atlanta AIDS Walk and the donations from Vystar and Alatech.
Oct. 15, 2009
- ATLANTA - Many leading regional, national and international news outlets picked up the Vystar press release announcing the launch of the Envy condom made with Vytex NRL. These include:
- San Francisco Chronicle (SFGate.com)
Vystar President and CEO Bill Doyle wrote a byline regarding the applications and benefits of Vytex NRL for medical devices.
July 30, 2009
- Vystar President and CEO Bill Doyle commented on 510(k) clearance from the U.S. Food and Drug Administration to market and sell the first exam gloves made with Vytex NRL.
July 29, 2009
- ATLANTA - Many leading regional, national and international news outlets picked up the Vystar press release announcing the FDA clearance for the first exam gloves made with Vytex NRL. These include:
July 1, 2009
- Vystar has partnered with the American Latex Allergy Association to provide information and resources about the benefits and applications of Vytex NRL. Read more about Vytex NRL on the Related Topics page.
By Aaron Pressman of Business Week
July 27, 2009
- There comes a time in the lives of most investors when they hear – or overhear – talk about a hot startup, often one just getting off the ground. The question many investors have is whether they can get in on the action before such a company goes public. The answer is: “Yes, but...” Opportunities for individuals to get in on these private capital deals are very limited, both because there’s often great interest from large venture capital funds and because regulations all but prohibit small investors from taking part.
Spring 2009 Issue
- Vytex Natural Rubber Latex (NRL), an enhanced latex material with ultra-low levels of antigenic proteins, could eliminate the risk of developing latex allergies.
by Chris Marr
July 9, 2009
- Vystar, the developer of a natural rubber latex designed to be less allergenic, has heard increased interest from potential acquirers and strategic investors since filing its IPO papers, said CEO William Doyle. While the company is having discussions with the interested parties, he said its most likely near-term strategy is to grow independently, perhaps even considering an acquisition of its own.
Vytex™ Natural Rubber Latex (NRL), a patented specialty chemical that virtually eliminates allergy-causing proteins found in latex, could prevent allergies from developing.
By Mike McNulty
Vystar Corp. President and CEO Bill Doyle announced the first product made with Vytex™ NRL – the Envy condom – which will be manufactured by Alatech Healthcare LLC. A revolutionary consumer product, the Envy condom will have significantly reduced levels of antigenic proteins. The product will carry labeling that will reflect the lowest antigenic protein content currently available in a natural rubber latex medical device in the U.S.
First consumer product to be manufactured with Vytex™ NRL
ATLANTA - Many leading regional, national and international news outlets picked up the Vystar press release announcing the FDA clearance for the new Envy™ Natural Rubber Latex Condom. These include:
- Sacbee.com (Sacramento Bee)
By Bill Doyle
Bill authored a byline article on the technology behind Vytex NRL and its application to medical devices for the magazine?s "advanced materials" section.
Vystar Corporation President and CEO Bill Doyle discussed industry trends regarding new technologies in the Atlanta Business Chronicle?s Technology in Motion
Vytex Natural Rubber Latex (NRL) is a patented specialty chemical that reduces antigenic proteins found in natural latex, which could prevent latex allergies from developing.
Vystar Corp. (Duluth, GA) is working with more than 45 manufacturers to conduct trials worldwide where Vytex is substituted for traditional latex or synthetic alternatives in numerous products including exam and surgical gloves, condoms, foams/bedding products, adhesives and coatings.
Bill Doyle, president and CEO of Vystar Corp., said, "Vytex™ NRL tackles the problem of latex allergies by virtually eliminating proteins that cause the allergy, possibly making VytexTM NRL safe for people to use without fear of developing latex protein allergy."
by Jeannie Akridge
Atlanta-based Vystar Corporation has developed Vytex NRL, a natural rubber latex in which the antigenic proteins are deactivated without affecting the desirable properties of latex. Alatech Healthcare has filed an FDA 510(k) for an exam glove made with Vytex NRL, as well as one for a condom. "To date, well over 500 protein test have been performed on Vytex and various products made with Vytex," said Bill Doyle, president and CEO of Vystar Corp. "While the protein level in latex can vary from tree to tree and season to season, we carefully monitor the protein levels, especially antigenic protein levels of Vytex NRL to ensure that users are exposed to significantly reduced levels of proteins in Vytex NRL and products made with Vytex NRL."
Vystar Corp. has introduced Vytex, a natural rubber latex made using a patented technology designed to remove the proteins that cause allergic reactions.
The process has been engineered to retain the desirable characteristics of latex, such as strength, elasticity and tactile sensitivity, according to Bill Doyle, president and chief executive officer of the Duluth, Ga.-based company. He said the process is relatively simple and that additional costs for foam made from the latex would be "negligible."
Vytex allows latex rubber, already considered a ?green? product, to stay green but removes proteins, Doyle said.
Doyle said the treatment process is best done at the source of the latex rubber?harvesting sites in southeast Asia. The process is being used by Revertex Malaysia, a latex processing company that treats the rubber and then sells the treated liquid latex to companies that will make it into cushioning foam.
The treated latex has been on the market since June and some bedding manufacturers are trial-testing the finished latex foam, according to the company.
by Heath Hamacher
DULUTH-A local company believes it has the solution for the three million Americans who suffer from latex-related allergies. Duluth-based Vystar Corp. has patented a chemical executives said removes just about all the allergy-causing proteins from natural rubber latex while allowing it to retain all of its positive characteristics.
Company president and chief executive officer Bill Doyle said the chemical, Vytex, will possibly make it safe for everyone to use latex without the fear of developing allergies.
Atlanta biotech company supports 30 manufacturing trials worldwide
ATLANTA-Many leading news agencies pick up Vystar Press Release announcing over 30 manufacturer trials with Vytex Natural Rubber Latex (NRL). Some of the agencies include:
ATLANTA-Latex allergies can limit or end the career of medical professionals who deal with latex-based medical devices constantly.
Latex allergies tend to develop over time from continual contact with latex materials. The allergy is relatively rare in the general population with approximately 3 per cent suffering fro the allergy, but it can affect up to 17 per cent of health care workers. Like other allergies, the severity of the reaction can range: in mild cases, individuals could have only skin irritation but in severe cases, patients can go into anaphylactic shock when exposed to latex.
If you are allergic to latex, the problem is with the proteins in the substance. This is where Vystar comes in.
Vystar Corp is an Atlanta-based startup that has developed a new patented technology that reduces the protein responsible for latex allergy to nearly undetectable levels. The company was founded in 2000, and has raised $7 million in private investment since 2004 alone.
Clearly, the technology has investors interest.
There?s good reason for that interest. Some health care professionals have been forced to leave their work due to latex allergy. At a time when medical care is at a premium, losing professionals at the peak of their abilities due to allergy is a burden on both the individual and society.
While reducing the allergen is good news, the question is whether the medical devices will continue to function properly. In most cases, latex is used for medical grade gloves that provide protection to the health care worker from patient bodily fluids. Vystar CEO, Bill Doyle, says that Vytex NRL reduces the allergens while maintaining critical product qualities, including barrier protection, strength and durability.
Consumers will have to wait to buy this product themselves. Vystar has just signed a manufacturing agreement with a US manufacturer of condoms and straight dipped gloves to develop products made with Vytex NRL. However, final biocompatibility tests with the US FDA are still pending.
by Joel Furfari
There are thousands of uses for latex. It stretches easily and is impermeable. It's impossible to imagine a hospital emergency room without nurses pulling on latex gloves. But for the millions of people who are allergic to conventional latex contact with the material causes itchy, irritated skin and occasionally even serious anaphylactic reactions akin to severe bee stings.
A Duluth-based research company named Vystar Corp may have an answer for these people. The firm is developing a latex product called Vytex™ Natural Rubber Latex that lacks the series of specific proteins that can irritate the skin.
by Allen Maurer
ATLANTA-If you are a doctor or a nurse and develop an allergic reaction to the latex, it can end or limit your career. Vystar Corp., an Atlanta startup has developed a patented technology that reduces the antigenic protein responsible for the allergy in natural latex products to nearly undetectable levels.
by Jeannie Akridge
There are a lot of factors that go into making a smart glove selection. Key features to consider in any glove evaluation include, but are not limited to: barrier protection, comfort, fit, feel, tactile sensitivity, elasticity, modulus, donnability, durability, tensile strength, puncture resistance, chemical resistance, texture, allergenicity, cost-effectiveness and even standardization issues.
Over 25 news agencies pick up Vystar Press Release announcing the signing of a production agreement for Vytex™ Natural Rubber Latex (NRL) with Revertex Malaysia. Some of the agencies include:
- Atlanta Journal & Constitution/AJC.com
- The Earth Times
- LA Times
- MSN Money
- Kron 4 -Bay Area News
- RBC Dain Rauscher
Vystar's third technical paper, "Vytex NRL: The science behind ultra low protein natural rubber latex" is printed in full in the rubber industry's leading publication.
Vystar President William Doyle highlights the important upcoming events for Vytex NRL.
Vystar President William Doyle and Sivanyana Moorthy, Head of Technical Department, Revertex Malaysia discuss the allergy issues surrounding natural rubber latex and Vystar's solution to the problem with Vytex NRL.
It’s been more than 20 years since the AIDS epidemic
and O.S.H.A. regulations made the simple latex glove
a mandatory presence…read
Travis Honeycutt, who holds about 100 patents, will
soon be marketing an invention that could change
the lives of many health-care workers…read
Atlanta-based Vystar Corporation will introduce
its revolutionary new latex named Vytex™ NRL to
manufacturers of latex products at the International